Medical Director and CMO Compensation (2026): How Physicians Get Paid for Administrative Time — and the Federal Law That Governs Every Dollar of It

What Counts as an "Administrative" or "Non-Clinical" Physician Role

Before the compensation and legal mechanics, it helps to map the actual landscape of roles this guide covers, because they span an enormous range of scope, time commitment, and pay structure.

Medical Director (department or service line level): The most common administrative role. A physician — often already on staff clinically — is paid an additional stipend for defined oversight duties: developing clinical protocols, supervising quality metrics, chairing departmental meetings, credentialing input, and serving as the clinical point of contact for a specific department (cardiac cath lab, imaging center, dialysis unit, hospice program, skilled nursing facility, urgent care network). Typically structured as a fractional FTE — 0.1 to 0.3 FTE is common — paid either as a flat monthly stipend or an hourly rate against a defined or estimated monthly hour commitment.

Associate/Vice President of Medical Affairs (VPMA): A step up in scope and typically a larger FTE commitment (0.5 FTE or greater, sometimes full-time), overseeing multiple service lines, physician relations, and often reporting directly to the CMO.

Chief Medical Officer (CMO): Typically a full-time, C-suite executive role — the physician leader responsible for the entirety of an organization's clinical strategy, quality and safety programs, medical staff relations, and increasingly, the clinical governance of AI and algorithmic decision-support tools deployed across the health system. CMOs almost universally give up meaningful clinical practice time, and many transition out of clinical practice entirely.

Medical Director, Medical Affairs (industry/pharma/payer setting): A structurally different role — physicians employed by pharmaceutical companies, biotechs, or health insurers in medical affairs, utilization review, or clinical strategy roles. These roles exist outside the hospital/health-system referral relationship that triggers Stark Law analysis in most cases, and compensation is typically structured as standard executive employment rather than a fractional physician services agreement.

What Medical Directors and CMOs Actually Earn in 2026

Compensation data for administrative physician roles is genuinely more fragmented than clinical salary data, because these roles are priced individually against fair market value benchmarks rather than aggregated the way clinical wRVU compensation is — and because the appropriate benchmark depends heavily on scope, FTE percentage, specialty, and organizational size.

Broad market benchmarks (blended across specialties and settings):

The wide spread between these figures — from under $90/hour to nearly $230/hour on an "average" basis — reflects the fact that "medical director" is not one job. A 0.1 FTE department medical directorship and a full-time system CMO role are being averaged into overlapping datasets by different survey methodologies, and the number that applies to you depends entirely on the scope and FTE percentage of the specific role you are evaluating.

What fractional, part-time medical director roles actually pay in practice:

The physician-reported reality, discussed candidly in physician financial communities, is more granular and arguably more useful than the blended survey averages above. One practicing physician describes a 0.15 FTE system-wide medical director role compensated at $125 per hour, describing this as the standard rate their organization applies to all part-time administrative physician work regardless of specialty — noting that for their own specialty, this represented a modest pay cut relative to clinical hourly equivalent, while for other specialties, particularly higher-wRVU procedural fields, the same $125/hour rate represents a considerably larger gap from clinical opportunity cost.

Another physician reports a 0.5 FTE director-level role benchmarked at $260,000 annually within their specialty — again below what that physician earns clinically, illustrating a consistent pattern: administrative hourly rates are frequently set as a single organization-wide or near-organization-wide standard, rather than scaled to match each individual physician's clinical specialty rate. This is not an oversight — it is often a deliberate compliance choice, discussed further below.

The tiered compensation structure some large systems use:

Larger health systems frequently operate structured, multi-tier administrative pay scales — for example, a six-tier system with a maximum hourly rate around $250/hour at the most senior non-C-suite administrative tier, with defined caps on total compensable hours per role. Physicians in these systems report an important practical caveat: the actual time commitment required by a role frequently exceeds the capped, compensable hours built into the contract — meaning the effective hourly rate, calculated against actual hours worked rather than contracted hours, is often meaningfully lower than the stated rate. If the role also displaces clinical wRVU-based compensation hour-for-hour, the financial impact compounds further.

Why This Isn't Just a Compensation Negotiation: The Stark Law Framework

This is the section that makes administrative physician compensation categorically different from every other topic on this site, and it is worth understanding at real depth before evaluating or negotiating any directorship offer.

What the Stark Law is and why it exists. The federal Physician Self-Referral Law — universally known as the Stark Law, codified at 42 U.S.C. § 1395nn — prohibits a physician from referring Medicare or Medicaid patients for certain "designated health services" to an entity with which the physician (or an immediate family member) has a financial relationship, unless that relationship fits squarely within a specific statutory exception or regulatory safe harbor. Congress passed this law because it recognized a basic economic reality: a physician who has a financial stake in where a patient is referred has an incentive that can conflict with the patient's best clinical interest — and a medical directorship fee is, definitionally, exactly this kind of financial relationship between a referring physician and the entity receiving those referrals.

The critical fact every physician considering a directorship needs to understand: Stark is a strict liability statute. No proof of bad intent, corrupt purpose, or even awareness of wrongdoing is required for a violation to exist. An arrangement that fails to meet every element of an applicable exception is a violation — full stop, regardless of how well-intentioned both parties were, and regardless of whether the physician actually did the work the agreement described. This is fundamentally different from ordinary contract law, where intent and good faith performance typically matter enormously.

The Anti-Kickback Statute (AKS) is a separate, overlapping law that adds a second layer of risk. Unlike Stark, the AKS is a criminal statute requiring proof of intent — but courts apply what is often called the "one-purpose test": if inducing referrals is even one purpose behind a payment, alongside other legitimate purposes, the statute can still be violated. Critically, satisfying an AKS safe harbor does not automatically mean an arrangement satisfies Stark, and satisfying a Stark exception does not automatically mean an arrangement satisfies the AKS. Every medical director or CMO agreement involving a physician who refers patients to the paying entity needs to be independently evaluated against both statutes.

The Personal Services Arrangement Exception: The Legal Home of Most Medical Director Agreements

For physicians who are not W-2 employees of the entity paying them — a common structure for part-time medical directors who maintain an independent practice elsewhere — the relevant Stark exception is the Personal Services Arrangements exception (42 CFR § 411.357(d)). This is the specific regulatory home for medical director agreements, on-call compensation arrangements, and consulting arrangements between hospitals or health systems and non-employee physicians.

To qualify for this exception, the arrangement must meet all of the following elements:

• •The agreement must be in writing and signed by both parties before services begin.
• •It must specify the covered services with reasonable precision — vague, catch-all descriptions of duties create compliance risk.
• •The aggregate services contracted for must not exceed what is reasonable and necessary for the legitimate business purposes of the arrangement — in plain terms, you cannot be paid for more oversight than the department genuinely needs.
• •The term must be for at least one year — though CMS has clarified this requirement can be satisfied even without an explicit one-year term stated in the contract, as long as the arrangement is in fact in effect for at least one year, or if terminated earlier, the parties do not enter into a substantially similar arrangement before that year would have expired.
• •Compensation must be set in advance, must be consistent with fair market value, and must not be determined in any manner that accounts for the volume or value of referrals generated by the physician.
• •The arrangement must be commercially reasonable even if no referrals were ever made between the parties.
• •The services must not involve counseling or promoting any activity that violates federal or state law.

For physicians who are genuinely employed as W-2 staff (most full-time CMOs, for example), the parallel bona fide employment relationship exception applies instead, with substantially similar core requirements: the employment must be for identifiable services, compensation must be consistent with fair market value and not tied to referral volume or value, and the arrangement must be commercially reasonable independent of referrals.

Fair Market Value and Commercial Reasonableness: Two Separate Tests, Both Required

This is the single most misunderstood concept in physician administrative compensation, and it is worth stating plainly: fair market value and commercial reasonableness are independent legal requirements. An arrangement must satisfy both — being priced correctly does not automatically make an arrangement legal.

Fair Market Value (FMV), as clarified in CMS's 2021 final rule, means the compensation that would result from an arm's-length transaction between well-informed parties who are not otherwise in a position to generate business for each other — essentially, what a reasonable, informed buyer and seller would agree to in a market untainted by the referral relationship. Notably, CMS has explicitly declined to create any "safe harbor" formula or rebuttable presumption that guarantees a given number is FMV. There is no universal rate card. Each arrangement must be evaluated on its own facts, which is precisely why formal, independent third-party FMV opinions are standard practice for higher-value or higher-risk arrangements — typically recommended for medical director fees above defined dollar thresholds, compensation set at or above the 75th percentile of relevant survey data, or arrangements involving physicians who generate significant referral volume to the paying entity.

Commercial reasonableness is a genuinely separate concept from valuation. CMS defines it as whether the arrangement "furthers a legitimate business purpose of the parties" and "is sensible, considering the characteristics of the parties, including their size, type, scope, and specialty" — and critically, an arrangement does not need to be profitable to be commercially reasonable. The clearest illustration of why these two tests are separate: a hospital determines that fair market value for a cardiac catheterization lab medical director is $150 per hour — a conservative, well-supported number. If that same hospital already has a fully functioning medical director in place performing those exact duties, and enters into a second, redundant medical director arrangement with another physician at the same $150/hour FMV rate, the second arrangement can still fail the commercial reasonableness test entirely — because the service being purchased is duplicative and serves no legitimate independent business purpose. A perfectly priced arrangement can still be illegal.

The "Work-Time Equation": Proving You Actually Did the Job

Because Stark and AKS compliance ultimately depend on the arrangement reflecting genuine services actually performed — not simply a payment made in exchange for referrals dressed up as a directorship — physicians in these roles carry a real documentation burden that clinical compensation does not typically require.

The basic mechanics: if a medical director agreement pays $5,000 per month and the contracted FMV hourly rate is $250, the implied expectation is approximately 20 hours of documented administrative work per month. Compliance-conscious organizations increasingly expect — and physicians should proactively maintain — contemporaneous time logs demonstrating that the hours billed correspond to actual oversight activity: meeting attendance, protocol review, chart audits, quality committee participation, credentialing input, and similar documented administrative work.

Why this matters practically for the physician, not just the compliance department: federal and state enforcement increasingly relies on data-driven audits to identify what is sometimes described as a "sham directorship" — an arrangement where compensation is high but there is no corresponding evidentiary record of actual oversight work performed. A physician who accepts a well-paying directorship and then fails to consistently document their administrative hours is not just creating risk for the organization — they are creating personal exposure, since Stark's strict liability standard does not require the organization to have acted in bad faith for a problem to exist, and a poorly documented arrangement is the first thing scrutinized in any subsequent audit, investigation, or transaction diligence process (medical director compensation is a standard diligence item in any private equity or health system acquisition of a physician practice).

The practical takeaway: if you accept a medical director or CMO role, treat the hours as seriously as you would treat clinical documentation. Keep a contemporaneous log. Retain meeting agendas, emails, and work product that corroborate the time. This is not bureaucratic overcaution — it is the evidentiary record that protects both you and the organization if the arrangement is ever reviewed.

Compensation Structures That Are Prohibited or High-Risk

Several compensation structures that might seem reasonable on their face are specifically disfavored or outright prohibited under this framework, and physicians evaluating a directorship offer should recognize them immediately.

Percentage of revenue or collections. Paying a physician a percentage of a clinic or department's gross or net revenue is generally treated as unlawful fee-splitting in states with strong corporate practice of medicine (CPOM) restrictions, and independent of CPOM concerns, directly implicates the "volume or value of referrals" prohibition at the core of both Stark and the AKS. This structure is essentially never appropriate for a medical director arrangement.

Per-procedure or per-click fees. Paying a director a small fee tied to each procedure performed, each unit of a service dispensed, or each use of a specific device or facility creates a direct financial incentive to increase volume — precisely the inducement the AKS is designed to prevent — and is a well-established compliance red flag regardless of how the arrangement is otherwise labeled.

"Free" perks in lieu of cash compensation. Providing free office space, marketing support, administrative staff, or other in-kind benefits to a physician in connection with a directorship — without arm's-length, fair-market payment for that value — constitutes non-monetary remuneration and is scrutinized just as closely as cash payment under both Stark and the AKS.

Compensation dramatically disproportionate to the entity's scale or need. An organization generating modest revenue that pays an outsized directorship fee — for example, a clinic with limited revenue paying a director a fee that would only make commercial sense for a much larger operation — raises commercial reasonableness concerns independent of whether the hourly rate itself can be benchmarked to a survey.

The State Law Layer: Corporate Practice of Medicine

Beyond the federal Stark Law and AKS framework, many states impose their own Corporate Practice of Medicine (CPOM) restrictions, which limit or prohibit non-physician entities from exercising control over clinical decision-making or splitting fees with physicians in ways state law considers improper. California is a particularly active and closely watched CPOM jurisdiction, and physicians evaluating administrative roles tied to management services organizations (MSOs) — a structure increasingly common as private equity and non-physician investors enter healthcare — should understand that these state-law restrictions operate as an additional, independent layer of compliance on top of the federal framework. A common structural response in CPOM-sensitive states is to have the clinical entity (the physician-owned professional corporation or PLLC) pay the physician director specifically for clinical oversight duties, while the MSO separately compensates for genuinely non-clinical administrative tasks — with the funds and duties clearly bifurcated to avoid claims that the MSO is improperly directing clinical care through its financial relationship with the director.

Because CPOM law varies meaningfully by state and interacts in complex ways with federal Stark/AKS compliance, any physician entering a directorship arrangement connected to an MSO or corporate-affiliated structure should have the arrangement specifically reviewed by healthcare regulatory counsel familiar with their state's CPOM framework — this is not a do-it-yourself compliance question.

The Honest Financial Calculus: Is Administrative Work Worth It?

Setting the legal framework aside, the practical financial question every physician considering a directorship or CMO role should ask is simple: does this pay more or less than my clinical hourly equivalent, and does that math change my answer?

For most specialists, in most part-time directorship roles, the honest answer is that it is a financial pay cut per hour. A physician earning $300 to $400 per hour of clinical time (reflecting typical wRVU-based compensation for many procedural and cognitive specialties covered elsewhere on this site — see our Physician Salary by Specialty guide) who accepts a directorship paying $125 to $250 per hour is, on a pure hourly basis, taking a pay cut for every hour spent on administrative duties instead of clinical work. This is a genuinely honest observation from physicians who have lived it: for just about any non-primary-care outpatient specialist, incremental administrative work is frequently a financial "money loser" relative to clinical opportunity cost, right up until a physician reaches roles one tier below full C-suite — at which point compensation for specialists can become genuinely competitive with clinical income.

Why physicians take these roles anyway — and when it makes sense:

The pipeline to full-time non-clinical leadership. A physician who wants to eventually transition into a full-time CMO or system-level medical affairs role — where compensation, as the data above shows, becomes genuinely comparable to or exceeds many clinical specialties — typically needs to build a track record through smaller, lower-paying directorship roles first. The early, financially suboptimal roles function as career capital, not primary income.

Burnout mitigation and career longevity. A physician who is systematically reducing clinical hours for sustainability reasons may rationally accept a lower blended hourly rate for administrative time in exchange for reduced clinical intensity, call burden, or malpractice exposure — a trade-off that is legitimate but should be evaluated with full awareness of its financial cost, not by accident. For the complete analysis of how burnout and financial planning intersect, see our Physician Burnout and Finances guide.

Influence over your own clinical environment. A physician who takes on a service line director role specifically to shape protocols, staffing, or quality metrics in their own department may reasonably value that influence independent of the hourly rate — a genuine non-financial return that a pure compensation analysis misses.

The risk that should factor into the decision: physicians who move into administrative roles and are later removed from them — due to organizational restructuring, performance disagreements, or simple changes in institutional priorities — frequently report difficulty returning to full-time clinical practice at their prior volume and income level. This is a real career risk that deserves the same weight as the compensation numbers themselves before accepting a role that meaningfully displaces clinical time.

What to Negotiate and Confirm Before Accepting a Directorship

Get the written agreement before you start any work. Because the Personal Services Arrangements exception requires the contract to specify covered services in advance and requires compensation to be set in advance and documented, an offer that has you "starting now, paperwork to follow" is a compliance problem waiting to happen — for the organization and, indirectly, for you.

Ask how the hourly rate or FTE percentage was determined. A well-run organization should be able to point to a specific benchmark source — MGMA DataDive, SullivanCotter, or an independent FMV opinion — rather than an arbitrary internal number. If the organization cannot explain its FMV methodology, that is itself a signal worth taking seriously.

Confirm the scope of duties is specific, not open-ended. Vague duty descriptions ("provide clinical leadership as needed") create both compliance risk and personal risk that your actual time commitment will exceed what you are being paid for. Push for a specific, itemized description of expected duties and, ideally, an estimated monthly hour commitment tied to the compensation.

Ask directly whether any other physician currently holds or has recently held this same role. Given the duplicative-services commercial reasonableness risk described above, this is a legitimate and reasonable diligence question — and an organization that hesitates to answer it clearly is worth a second look.

Set up your own time tracking from day one, independent of whatever system the organization uses. This protects you personally if the arrangement is ever scrutinized and gives you concrete data to support renewal or renegotiation of the role.

Understand the interaction with your clinical contract. If the directorship is layered on top of an existing clinical employment agreement, confirm how the two interact — whether directorship hours reduce your clinical wRVU expectations, whether the two compensation streams are reported and taxed separately, and whether the directorship agreement has its own independent term and termination provisions distinct from your clinical employment. For the complete framework on evaluating physician employment terms generally, see our Physician Contract Negotiation guide and Physician Contract Red Flags guide.

Have the arrangement reviewed by counsel if the compensation is significant or you have any doubt about the structure. This is genuinely one of the situations on this site where "consult a professional" is not boilerplate caution — it is the specific, correct answer, because the strict liability nature of Stark Law means good intentions do not protect you from a poorly structured arrangement.

Frequently Asked Questions